Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Research updates

Browse dated psilocybin research updates, separate publication dates from indexing dates, explore monthly literature and follow confirmed research alerts.

Free access · No subscription for research tools or data exports

Observed research changes

Changes are recorded when registry data are refreshed. The initial snapshot is a baseline, not historical news. A registry-added result reference may point to an older publication; its observation date is not the paper's publication date.

Recruitment status changed to recruiting · NCT07582120A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression · observed Nov 18, 2026 02:23 UTCRecruitment status changed to recruiting · NCT07719088An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life · observed Nov 18, 2026 02:23 UTCRegistry status changes · NCT06919640Psilocybin With Intracranial Neural Sensing · observed Nov 13, 2026 02:33 UTCRecruitment status changed to recruiting · NCT07296328Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter · observed Nov 11, 2026 02:25 UTCRecruitment status changed to recruiting · NCT07756736Psilocybin Recovery Intervention for Stopping Methamphetamine Use · observed Nov 10, 2026 02:27 UTCRegistry status changes · NCT06786325A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)? · observed Nov 7, 2026 02:23 UTCRegistry status changes · NCT06660381Pilot Study of Psilocybin-assisted Treatment for Cannabis Use Disorder · observed Nov 6, 2026 02:24 UTCFirst observed recruiting · NCT07920081Psilocybin for Amblyopia - Targeting Critical Periods in Humans (PATCH) · observed Nov 6, 2026 02:24 UTCRegistry status changes · NCT05351541A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain · observed Nov 5, 2026 02:25 UTCRegistry status changes · NCT06001749Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer · observed Oct 28, 2026 02:24 UTCRecruitment status changed to recruiting · NCT07405606Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial · observed Oct 27, 2026 02:22 UTCRecruitment status changed to recruiting · NCT07391332Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study · observed Oct 17, 2026 01:22 UTCRegistry status changes · NCT05554094Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial · observed Oct 17, 2026 01:22 UTCRegistry status changes · NCT05224336Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb Pain · observed Oct 12, 2026 07:04 UTC

Opt in to research-change email alerts. Journal and citation filters apply to publications; use keyword, sponsor/author and topic filters for registry changes.

Monthly literature view

80 records have publication dates within this month. Issue dates may be assigned ahead of online availability. Date-added activity and publication-date activity describe different events.

Modelling vortex interactions reveals distinct patterns of brain reconfiguration following psilocybin and escitalopram2026-11-19 · bioRxiv · PREPRINT (not peer reviewed)Psilocybin reproducibility2026-11-19 · Crossref · PublishedMescaline enhances emotional empathy via 5-HT receptor activation.2026-11-19 · PubMed · PublishedTargeting CGRP signaling reverses maladaptive neurogenic immunosuppression in head and neck squamous cell carcinoma models.2026-11-19 · PubMed · PublishedTaxonomic diversity and psilocybin detection in “superfamily” Strophariacea from China, with descriptions of two new species2026-11-18 · Crossref · PublishedNovel quantification method for psilocin in brain tissues using liquid chromatography-tandem mass spectrometry.2026-11-18 · Europe PMC · PublishedA Placebo Cannot Be Psychedelic: Why psychedelic trials need dose, not mimicry, as their control2026-11-18 · PsyArXiv · PREPRINT (not peer reviewed)Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease2026-11-18 · ClinicalTrials.gov · CLINICAL TRIALToward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy2026-11-18 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin induces delayed and dynamic changes in human sleep neurophysiology: Results from a randomized controlled trial of psilocybin assisted therapy in patients with comorbid major depressive and alcohol use disorder2026-11-17 · Europe PMC · PREPRINT (not peer reviewed)Psychedelic treatment for headache disorders.2026-11-17 · Europe PMC · PublishedMultidimensional Self-Transcendent Experiences in Psychedelic Use: Distinct Associations with Mindset, Affect, and Positive Effects2026-11-17 · PsyArXiv · PREPRINT (not peer reviewed)An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life2026-11-17 · ClinicalTrials.gov · CLINICAL TRIALEfficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms2026-11-17 · ClinicalTrials.gov · CLINICAL TRIALA Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression2026-11-17 · ClinicalTrials.gov · CLINICAL TRIALTracking single neurons across days reveals acute and persistent effects of psilocybin in the mouse brain2026-11-16 · bioRxiv · PREPRINT (not peer reviewed)The social conditioned place preference assay is sensitive to drug dose, training regimen, and social context2026-11-16 · bioRxiv · PREPRINT (not peer reviewed)Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study2026-11-16 · ClinicalTrials.gov · CLINICAL TRIALPrior trauma shapes the effects of psilocybin on stress sensitization in mice.2026-11-15 · PubMed · PublishedQuality of Life and the Case for Consent-Based Psilocybin Access - Questions on the Regulatory Framework and Cost2026-11-14 · PsyArXiv · PREPRINT (not peer reviewed)Psilocybin-Assisted Therapy for Existential Distress in Serious and Life-Limiting Illness: Emerging Trial Evidence, Barriers to Access, and the Case for Individualized Eligibility2026-11-14 · PsyArXiv · PREPRINT (not peer reviewed)Cost-effectiveness of psychedelic-assisted therapies for depression and post-traumatic stress disorder: A systematic review.2026-11-13 · Europe PMC · PublishedRoots to Thrive risk and readiness assessment: a practice-based intake and decision-support framework for psychedelic-assisted therapy.2026-11-13 · PubMed · PublishedCurrent perspectives in the pharmacological treatment of gambling disorder: psychedelics and beyond.2026-11-13 · Europe PMC · PublishedPsilocybin enhances conditioned place preference learning in planarians.2026-11-13 · Europe PMC · PublishedHow Does Psilocybin Affect Daily Life Experience and Behavior? Protocol For a Multimethod Ambulatory Assessment Study Within a Clinical Trial of Psilocybin for Depression2026-11-12 · medRxiv · PREPRINT (not peer reviewed)Connectedness as a candidate pathway linking psilocybin retreat experiences to sustained wellbeing: a prospective naturalistic study2026-11-12 · Europe PMC · PublishedThe Effects of Psilocybin on Social Connectedness2026-11-12 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin With Intracranial Neural Sensing2026-11-12 · ClinicalTrials.gov · CLINICAL TRIALNeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy2026-11-12 · ClinicalTrials.gov · CLINICAL TRIALA Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder2026-11-12 · ClinicalTrials.gov · CLINICAL TRIALFrom Rapid Synaptic Events to Lasting Antidepressant States: Convergent and Divergent Mechanisms of Ketamine and Psychedelics.2026-11-11 · Europe PMC · PublishedExploring subacute effects of a DMT and harmine meditation retreat on the brain's control energy landscape2026-11-11 · bioRxiv · PREPRINT (not peer reviewed)The "dark magic mushroom" co-produces amatoxins and psilocybin.2026-11-11 · Europe PMC · PublishedPsychedelic-assisted therapies (Psilocybin and MDMA) for treatment-resistant psychiatric disorders2026-11-10 · Crossref · PublishedChanges in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients2026-11-10 · Crossref · PublishedEffects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter2026-11-10 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin for anorexia nervosa: efficacy, safety, and durability of clinical effects: a systematic review of clinical trials2026-11-09 · Crossref · PublishedPsilocybin Recovery Intervention for Stopping Methamphetamine Use2026-11-09 · ClinicalTrials.gov · CLINICAL TRIALRapid antidepressant effects of psilocybin without increased SV2A binding: baseline binding predicts response2026-11-08 · medRxiv · PREPRINT (not peer reviewed)Psilocybin-assisted therapy for alcohol use disorder: A systematic review of randomized controlled trials2026-11-06 · Crossref · PublishedPharmacist Guide to Psilocybin and Psychedelic-Assisted Psychotherapy.2026-11-06 · Europe PMC · PublishedInvestigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder2026-11-06 · ClinicalTrials.gov · CLINICAL TRIALRole of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)2026-11-06 · ClinicalTrials.gov · CLINICAL TRIALA Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?2026-11-06 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin for Amblyopia - Targeting Critical Periods in Humans (PATCH)2026-11-05 · ClinicalTrials.gov · CLINICAL TRIALA Topology of the Psilocybin Experience Reveals Cognitive-Emotional Drivers, Unitive State Divergence, and Psychometric Feature Cancellation2026-11-05 · PsyArXiv · PREPRINT (not peer reviewed)Which Psychedelic Therapy Should Rural Health Systems Pursue First: Psilocybin or Ibogaine?2026-11-05 · Crossref · PublishedPsilocybin modulates nucleus accumbens activity via astrocytic transcriptional regulation.2026-11-05 · Europe PMC · PublishedA Phase 1b Study to Evaluate the Safety and Tolerability of MLS101 Treatment for Premenstrual Dysphoric Disorder (PMDD)2026-11-05 · ClinicalTrials.gov · CLINICAL TRIAL

Recently indexed records

These entries are ordered by when they entered this index, not when the underlying study was conducted or published. A newly indexed old paper is not a new finding.

Modelling vortex interactions reveals distinct patterns of brain reconfiguration following psilocybin and escitalopramIndexed 2026-11-20 02:22:21 · publication date 2026-11-19 · PREPRINT (not peer reviewed)Psilocybin induces delayed and dynamic changes in human sleep neurophysiology: Results from a randomized controlled trial of psilocybin assisted therapy in patients with comorbid major depressive and alcohol use disorderIndexed 2026-11-20 02:20:18 · publication date 2026-11-17 · PREPRINT (not peer reviewed)Psilocybin reproducibilityIndexed 2026-11-20 02:20:15 · publication date 2026-11-19 · PublishedCost-effectiveness of psychedelic-assisted therapies for depression and post-traumatic stress disorder: A systematic review.Indexed 2026-11-20 02:20:08 · publication date 2026-11-13 · PublishedMescaline enhances emotional empathy via 5-HT receptor activation.Indexed 2026-11-20 02:20:07 · publication date 2026-11-19 · PublishedTargeting CGRP signaling reverses maladaptive neurogenic immunosuppression in head and neck squamous cell carcinoma models.Indexed 2026-11-20 02:20:06 · publication date 2026-11-19 · PublishedTaxonomic diversity and psilocybin detection in “superfamily” Strophariacea from China, with descriptions of two new speciesIndexed 2026-11-19 02:20:12 · publication date 2026-11-18 · PublishedRoots to Thrive risk and readiness assessment: a practice-based intake and decision-support framework for psychedelic-assisted therapy.Indexed 2026-11-19 02:20:06 · publication date 2026-11-13 · PublishedPsychedelic treatment for headache disorders.Indexed 2026-11-19 02:20:06 · publication date 2026-11-17 · PublishedNovel quantification method for psilocin in brain tissues using liquid chromatography-tandem mass spectrometry.Indexed 2026-11-19 02:20:06 · publication date 2026-11-18 · PublishedMultidimensional Self-Transcendent Experiences in Psychedelic Use: Distinct Associations with Mindset, Affect, and Positive EffectsIndexed 2026-11-18 02:23:24 · publication date 2026-11-17 · PREPRINT (not peer reviewed)Tracking single neurons across days reveals acute and persistent effects of psilocybin in the mouse brainIndexed 2026-11-17 02:22:19 · publication date 2026-11-16 · PREPRINT (not peer reviewed)The social conditioned place preference assay is sensitive to drug dose, training regimen, and social contextIndexed 2026-11-17 02:22:19 · publication date 2026-11-16 · PREPRINT (not peer reviewed)Single-dose psilocybin superior to placebo for MDD in community settingIndexed 2026-11-15 02:20:13 · publication date 2026-12-01 · PublishedPilot study supports broader research on psilocybin for anorexia nervosaIndexed 2026-11-15 02:20:13 · publication date 2026-12-01 · Published